OBJECTIVES To evaluate the safety of neck liposuction in a large series of patients.
METHODS Between 2003 and 2011, 320 patients underwent liposuction of the neck. Complications were recorded, and all patients were followed up after 8 weeks.
RESULTS There were no serious complications. Four patients required closer follow-up because of hematoma (n = 1), transient mandibular nerve inflammation (n = 2),
and globus pharyngeus (n = 1).
CONCLUSION Liposuction of the neck with Nepicastat inhibitor tumescent local anesthesia requires a higher amount of patient monitoring than liposuction of the body. In the hands of an experienced surgeon, it is a safe method rendering excellent aesthetic results.”
“Studies on molecular biology have considerably enhanced our understanding of congenital Coagulation disorders but have failed so far to supply tools for an adequate classification of
defects. In fact, Mutations in the same domain may give rise to different phenotypes. Conversely, mutations in different domains, controlled by different exons, may cause similar patterns. The 37 kindreds with congenital factor X (FX) deficiency, known to have a defect in the catalytic domain, have been evaluated in an attempt to investigate the genotype-phenotype relation. Discrepant results were obtained because about half kindreds showed a type I pattern, namely a concomitant decrease in FX activity and antigen. The other half showed a selleck kinase inhibitor type II pattern, namely a decrease in FX activity with a normal or near normal FX antigen. In a few instances, the allocation of the kindred check details either to type I or to type II defect could not be reached, due to the lack of information about the antigen. The comparison of the kindreds in which the same mutation has been discovered by different investigations is not always possible also for lack of information. The study analyzes the need to have a multipronged approach to he study of congenital FX deficiency. The indication of a mutation in a given domain does not provide clear information about the phenotype.”
“Thermodegradation
behaviors of novel aluminum phosphate/cyanate ester (AIPO(4)(KH550)/CE) composites were studied in detail. Results show that thermodegradation behaviors and kinetic parameters of AIPO(4)(KH550)/CE composites are greatly dependent on the AIPO(4)(KH550) loading. The addition of AIPO(4)(KH550) into CE resin changes the thermodegradation mechanism (mainly at the temperature lower than 450 degrees C) mid degradation process from two steps to three steps. Comparing with CE resin, AIPO(4)(KH550)/CE composites have lower initial degradation temperature and greatly higher char yield. Besides, for each thermodegradation step, the more the AIPO(4) content, the smaller the activation energy value is. All reasons leading to these outcomes are investigated intensively. (C) 2009 Wiley Periodicals, Inc.